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Objective/background: Molecular typing tools, including spoligotyping, are currently widely
used in the monitoring and study of the dynamics of tuberculosis epidemics.
Methods: A study of the molecular profile of a sample of 129 Myobacterium tuberculosis
strains isolated during 2011 was carried out in the National Reference Laboratory for Tuber-
culosis and Mycobacteria at the Pasteur Institute of Algeria. This sample was selected at
random from a set of 350 strains isolated from tuberculosis patients from central and east-
ern areas of the country.
Results: Genotypic analysis helped to clarify the frequencies of the different genotypes in
the current study population: H family, 29%; LAM family, 26%; T family, 25%; S family,
5%, and other genomic families, including orphan strains, 15%.
Conclusion: The study of strains isolated between January and December 2011 has allowed
insight into the frequency of different genomic families and the importance of existing
clusters in the population of central and eastern Algeria.
 2015 Asian African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.Introduction
Tuberculosis (TB) is an infectious and contagious disease that
remains endemic in Algeria despite a long and well-
administered national TB control program (NTBP). Algeria is
classified by the World Health Organization into the group
of countries having moderate TB prevalence, with an annual
incidence of between 20 and 99 cases per 100,000 people
[1,2]. In 2011, the incidence of microscopy-positive pulmonary
TB cases was 19.4 out of 100,000 inhabitants, and the annual
incidence of total TB was 57.7 out of 100,000 that same year.
Molecular typing tools, including spoligotyping, are currentlywidely used in the monitoring and study of the dynamics of
tuberculosis epidemics. Using these tools, a retrospective
study of the strains isolated during the year 2011 was con-
ducted, involving a sample of 129 strains of Mycobacterium
tuberculosis isolated from TB patients diagnosed in the central
and eastern regions of the country.
Materials and methods
The study was performed on 129 strains of M. tuberculosis
identified from January 1st to December 31st, 2011. The study
material was drawn from 14 departments of central and
Table 1 – Demographic, clinical, and bacteriological charac-
teristics of patients.
Specifications General data
TB patients 129
Male 76 (58%)
Female 53 (42%)
Sex ratio (M/F) 1.43
Average age (y) 39
Patients with unknown age 9
Location of the TB
Pulmonary 114 (88%)
Extrapulmonary 15 (12%)
History of the disease
New cases 76 (59%)
Previously treated cases 53 (41%)
Results of susceptibility tests
Total strains tested 129 76NC 53PC
Sensitive strains 113 72 44
Resistant strains 13 4 9
H 1 0 1
S 2 1 1
HS 3 2 1
MDR (at least H+R)) 7 1 6
Contaminated 3
E = ethambutol; F = female; H = isoniazid; M = male;
MDR = multidrug resistant; NC = new cases; PC = previously trea-
ted cases; R = rifampicin; S = streptomycin; TB = tuberculosis.
Fig. 1 – Distribution of individuals in the study population between the 14 departments from central and eastern Algeria.
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confirmed by biochemical tests (nitratase, catalase) and by
sensitivity to chemical substances, such as 2-thiophene car-
boxylic acid (TCH), Sodium 4-aminosalicylate (PAS), 4
nitrobenzoic acid (PNB). Each strain corresponds to a patient.
The sensitivity tests for antituberculosis (isoniazid, strepto-
mycin, rifampicin, ethambutol, kanamycin, and ofloxacin)
were performed using the proportion method on
Lo¨wenstein-Jensen medium.
The strains included in the study were typed by spoligo-
typing [3,4]. The profiles obtained were analyzed by using
the SPOLDB4 database [5]. A dendrogram was produced with
the MIRU-VNTR software available on the website (http://
www.MIRU-VNTRplus.org, August 2008).
Results
Study population
The study was performed on 129 strains randomly selected
from a sample of 350 strains isolated from TB patients
between January and December 2011. Strains isolated from
pulmonary localization represent 88% of cases, while 12% of
cases represent extrapulmonary tuberculosis strains. The
sex ratio was 1.43 and the average age of patients was
39 years. The proportion of previously treated patients was
41% (53 patients) of the sample. The demographic, clinical,
and bacteriological characteristics of patients are reported
in Table 1.
Antituberculosis drug resistance
The results of the sensitivity tests were available for 126 iso-
lates (97.7%), of which 113 cases (89.7%) were sensitive to all
of the first-line antituberculosis drugs. The majority of thesestrains (76.6%) were isolated from new TB patients and 53
strains were isolated from previously treated patients.
Analysis of drug resistance profiles in patients previously
treated or new patients shows that among 13 drug-resistant
strains, nine were isolated from patients previously treated.
Among these, six are multidrug resistant. Of the four strains
isolated from new patients, one showed resistance to four
major antibiotics tested. The results appear in Table 1.
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Referring to the SPOLDB4 database [5], common spoligotypes
found within more than one strain were referred to as
‘‘shared types’’ and designated by a shared international type
number (SIT). The analysis of 129 strains revealed a very high
genetic diversity of 48 different spoligotypes. Among these,
117 strains (90.7%) are known profiles and 12 (9.3%) are not
yet listed (orphan profiles). The profile analysis revealed seven
large genomic families (clades). The predominance of
Haarlem clade (H) with 38 strains, Latin-American–Mediterr
anean (LAM) with 33 strains, the T clade with 32 strains,
and Sardinia–Sicily (S) with seven strains. Rare clades with
lower effectiveness corresponded to the U clade with three
strains, the X clade with one strain, the USA clade with one
strain, LAM10-CAM with one strain, and H3-LAM9 with one
strain. Genomic families are more diverse, with 15 subclades
in total. LAM is the most diverse family, with five subclades,
while the H and T families have three subclades each. The
LAM and H families are the most diverse, with 16 and 13 dif-
ferent spoligotypes, respectively. The total frequency of
strains clustered in relation to the total strains studied is
64.3% (83 strains), represented primarily by H, LAM, T, and S
clades.
The total number of observed clusters is 14, with the H
family having seven different clusters for 32 strains (24.8%
frequency), the LAM family having three different clusters
for 20 strains (15.5% frequency), and T family having 27
strains (20.9% frequency).
The dominant clusters were represented primarily by the
SIT n 53/T1 with 25.3% (21 strains), SIT n 50/H3 with 19.3%
(16 strains), and SIT n 42/LAM9 with 19.3% (16 strains). The
percentage of dominant clusters was determined relative to
the total number of clustered strains (Table 2).
Other lineages such as U, X, USA, LAM-CAM, and CAM-H,
were represented by 2.3% for U and 0.7% for each of the other
lineages, respectively. Additional details for the different pro-
files can be found in Fig. 2.
Comparison of the 12 strain profiles (9.3%) not listed in the
SPOLDB4 database [5] and the SITVITWEB database (Pasteur
Institute of Guadeloupe, 2012) (Fig. 2), has allowed us to relate
these profiles to certain clades. We were able to link the
strains n 006, 035, 050, 064, 090, and 126 to the H family,
the strain n 027 to the S family, strains n 029 and 096 to
the U family, and strains n 048, 062, and 066 to the LAM fam-
ily, knowing that the orphan profile n 066 was also found and
published in Portugal [6].Discussion
Besides their advantages in determination of genetic diversity
of circulating strains, molecular typing tools can detect
potential epidemiological links between TB patients.
Comparisons were established between the results of our
study and those obtained in four Mediterranean countries,
specifically Portugal [6], Tunisia [7], Italy [8], and France [9]
(Table 3).
This comparison aims to determine the largest genomic
families and dominant spoligotypes in the region. The
Fig. 2 – Dendrogram of the 129 strains typed by spoligotyping.
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 4 ( 2 0 1 5 ) 2 9 0 –2 9 5 293
Table 3 – Comparison of dominant clusters from the present study with results from Four Mediterranean countries.
Studies Study period Dominant clusters/clades
Algerian study—129 strains 2011 42/LAM9 12.4%
50/H3 12.4%
53/T1 16.3%
34/S 3.1%
Tunisia—378 strains [7] 2001–2005 42/LAM9 16.0%
50/H3 39.0%
53/T1 10.5%
34/S 1.3%
Italy (Tuscany)—248 strains [8] 2004 42/LAM9 5.2%
50/H3 5.0%
53/T1 11.7%
34/S 1.2%
France (Limousin)—259 strains [9] 1998–2006 42/LAM9 –
50/H3 8.0%
53/T1 13.0%
34/S –
Portugal—655 strains [6] 1999–2005 42/LAM9 10.5%
50/H3 2.5%
53/T1 8.0%
34/S 2.9%
H = Haarlem; LAM = Latin-American–Mediterranean; S = Sicily–Sardinia.
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nance of LAM, T, and H clades and the similar frequencies
of spoligotypes SIT n 42, 50, and 53. This distribution is likely
the result of the mixed populations located around the
Mediterranean basin.
The results obtained in this study were also compared to
the new SITVITWEB database (Pasteur Institute of
Guadeloupe, 2012) [10]. A first comparison was made between
all dominant spoligotypes from this study and the AlgerianFig. 3 – Comparison of dominant shared types from this
study with Algerian data in the SITVITWEB database
(Pasteur Institute of Guadeloupe, 2012) [10].
Fig. 4 – Comparison of dominant shared types in this study
with data from bordering geographic areas.data. This comparison indicated similarities particularly
between shared types n 42, 50, 53, and 196 (Fig. 3).
Another comparison between results from the five regions
bordering Southern and Western Europe, North and West
Africa, Western Asia, and the analysis of data from the cur-
rent study indicates that our results are similar to those
observed for North Africa, with approximately the same order
of frequency of the dominant clusters n 42, 50, and 53.
However, clade S, which appears in two geographically
adjacent regions (North Africa and Southern Europe), indi-
cates possible relationships between these two regions. The
discovery of clade S in our country is likely the result of fre-
quent travel and its past history of colonization (Fig. 4).Conclusion
Genotypic analysis on a sample of 129 typed strains isolated
from TB patients in 2011 helped to reveal the genetic diversity
of strains circulating in our study population (14 departments
from the central and eastern regions of Algeria). We identified
three genomic dominant families, H, LAM, and T represented
by 28.7%, 25.6%, and 25.6%, respectively. The frequency of
certain dominant clusters (cluster SIT n 42/LAM (12.4%), clus-
ter SIT n 50/H3 (12.4%), and cluster SIT n 53/T1 (16.9%)) has
been evaluated and indicates tuberculosis transmission. The
spoligotypes obtained can be used to enrich the genotyping
database of our country, which is currently insufficient.
A more exhaustive study covering the western and south-
ern regions of the country researching a larger number of
strains over a longer time period will be launched to provide
more representative results of the epidemiological situation.Conflict of interest
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